News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Jemperli (dostarlimab)
August 29, 2025
ctDNA Recurrence Monitoring in Endometrial Cancer
Charles H. Weaver, MD
April 8, 2025
Jemperli (dostarlimab) Treatment of Rectal Cancer
Charles H. Weaver, MD
February 9, 2022
Precision Cancer Medicines for Endometrial Cancer
Charles H. Weaver, MD
October 10, 2020
Treatment & Management of Rectal Cancer
Charles H. Weaver, MD
October 3, 2020
Treatment for Stages I – III Rectal Cancer
Charles H. Weaver, MD
June 6, 2020
Overview of Uterine Cancer
Charles H. Weaver, MD
April 27, 2020
Jemperli for Advanced Uterine/Endometrial Cancer
Charles H. Weaver, MD
April 12, 2019
Treatment & Management of Uterine Cancer
Charles H. Weaver, MD
August 13, 2018
Treatment of Recurrent Uterine Cancer
Charles H. Weaver, MD
August 13, 2018
Treatment of Stage IV Uterine Cancer
Charles H. Weaver, MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
